2025-04-10 - Analysis Report
## PepsiCo Inc (PEP) Stock Review

**0. Key Figures at a Glance:**

* **Cumulative Return (PEP):** 20.08%
* **Cumulative Return (VOO):** 66.94%
* **Return Difference:** -46.9% (Relative Divergence: 20.1%)
* **Current Price:** $145.59
* **Market Risk Indicator (MRI):** 0.5289 (High Risk)


**1. Performance Comparison:**

PepsiCo Inc (PEP) is a global food and beverage company producing a wide range of snacks, drinks, and other food products.  Over the period reviewed, PEP significantly underperformed the S&P 500 (VOO), lagging by 46.9%.  While the relative divergence of 20.1% suggests its performance is not at its historical worst compared to the S&P 500, it still indicates substantial underperformance.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 26.0% | 2.2% | -3.0% | 0.0 | 132.7 |
| 2016-2018  | 10.0% | 62.5% | -8.0% | 0.0 | 126.3 |
| 2017-2019  | 32.0% | 62.5% | 3.0% | 0.5 | 160.9 |
| 2018-2020  | 33.0% | 62.5% | 7.0% | 0.4 | 179.7 |
| 2019-2021  | 53.0% | 61.0% | -1.0% | 0.3 | 216.6 |
| 2020-2022  | 11.0% | 61.0% | 5.0% | 0.3 | 231.3 |
| 2021-2023  | 10.0% | 61.5% | -7.0% | 0.4 | 223.7 |
| 2022-2024  | -39.0% | 61.5% | -56.0% | 0.3 | 206.7 |
| 2023-2025  | -30.0% | 95.0% | -45.0% | 0.4 | 199.7 |

The table shows significant variation in CAGR across different periods.  Negative Alpha values in several years indicate underperformance relative to the market benchmark. Beta values generally hover around 0.3-0.5 suggesting a relatively low sensitivity to market movements compared to the S&P500 (Beta=1).  The substantial market capitalization consistently exceeding $100B demonstrates the company's size and market standing.  However, the recent negative CAGRs are concerning.

**2. Recent Price Movement:**

* **Closing Price:** $145.59
* **5-Day Moving Average:** $145.41
* **20-Day Moving Average:** $147.67
* **60-Day Moving Average:** $148.07

The price is slightly below the 5-day and significantly below the 20- and 60-day moving averages suggesting a potential downward trend. The recent price increase (Last-market data) shows a 3.77 increase from the previous close, indicating a potential short-term bounce.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.5289 (High Risk) â€“ Indicates elevated market volatility.
* **RSI:** 47.24 (Neither overbought nor oversold, but leaning towards bearish)
* **PPO:** -0.42 (Negative value suggests bearish momentum)
* **20-Day Relative Divergence Change:** +4.3 (Short-term upward trend)
* **Expected Return (Long-term):** -21.3% (Significantly below market expectation; suggesting underperformance relative to the S&P 500 over the next two years or longer).  This significant negative expected return warrants further investigation into the underlying assumptions.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-08 | 2.13 | $23.32 B      |
| 2024-07-11 | 2.24 | $22.50 B      |
| 2024-04-23 | 1.49 | $18.25 B      |
| 2023-10-10 | 2.25 | $23.45 B      |
| 2024-10-08 | 2.25 | $23.45 B      | *(Note: Duplicate entry)*

There's a duplicate entry for October 8th, 2024.  Excluding the duplicate, revenue shows some fluctuation, with a dip in Q1 2024. EPS also shows variability, suggesting potential factors affecting profitability.  A more detailed analysis, including year-over-year comparisons and industry benchmarks, is needed for a comprehensive assessment.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue   | Profit Margin |
|---------|-----------|---------------|
| 2024-12-31 | $27.78B  | 52.56%       |
| 2024-09-30 | $23.32B  | 55.42%       |
| 2024-06-30 | $22.50B  | 55.92%       |
| 2024-03-31 | $18.25B  | 54.81%       |
| 2023-12-31 | $27.85B  | 52.97%       |

Revenue shows seasonality, with higher figures in Q4. Profit margins are consistently high, indicating strong profitability.

**Capital and Profitability:**

| Quarter | Equity    | ROE    |
|---------|-----------|--------|
| 2024-12-31 | $18.04B  | 8.44%  |
| 2024-09-30 | $19.45B  | 15.06% |
| 2024-06-30 | $19.45B  | 15.85% |
| 2024-03-31 | $19.05B  | 10.72% |
| 2023-12-31 | $18.50B  | 7.04%  |

Equity and ROE show some fluctuation.  The high ROE in Q2 and Q3 suggests strong utilization of equity capital during those periods.

**6. Overall Analysis:**

PEP has shown significant underperformance compared to the S&P 500 over the reviewed period. While profitability and margins remain strong, recent earnings and price movements show volatility and a potential downward trend. The high market risk indicator and negative long-term expected return raise concerns.  Further investigation is needed to understand the reasons behind the underperformance and the accuracy of the negative long-term expected return. A deeper dive into industry comparisons, macroeconomic factors, and company-specific news is necessary for a complete and informed investment decision.  The current data suggests a cautious approach to investing in PEP at this time.
